ArticleThe Journal of antimicrobial chemotherapy2016

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.

Oliver A Cornely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.